Natural carriage of Streptococcus pneumoniae is associated with increased experimental pneumococcal carriage but reduced conjugate vaccine efficacy in a human challenge model.
We investigated the relationship between natural and experimental pneumococcal carriage, focusing on the impact of natural carriage on vaccine efficacy. Statistical analyses were carried out according to a pre-specified Statistical Analysis Plan using R v.4.2.2 (R Development Core Team, Vienna, Austria) and GraphPad Prism v9.0.0 (Graph-Pad Software, San Diego, California, USA). Two key findings emerged: firstly, individuals with natural carriage were more likely to become experimental carriers, and secondly, the efficacy of the PCV-13 vaccine in preventing experimental carriage was reduced in those with natural carriage. Serotype exchange as well as co-colonisation with experimental carriage was observed in 15 participants. We concluded that natural carriage could impact vaccine efficacy in high-prevalence settings, emphasizing the importance of vaccine design targeting reductions in natural carriage. The use of carriage reduction as a trial endpoint was encouraged, along with the adoption of batched samples and molecular diagnostics to enhance trial efficiency.
Funding
Malawi Accelerated Research in Vaccines, Experimental and Laboratory Systems
Wellcome Trust
Find out more...